| NOVACTA BIOSYSTEMS LIMITED Patent applications |
| Patent application number | Title | Published |
|---|
| 20110306091 | LANTIBIOTIC BIOSYNTHETIC GENE CLUSTERS FROM A. GARBADINENSIS AND A. LIGURIAE - This invention relates to characterisation of the biosynthetic gene cluster for the lantibiotic actagardine, identification of a novel variant of actagardine and its biosynthetic cluster, and methods of production and use of actagardine, a novel actagardine variant, herein referred to as actagardine B, and variants of both of these produced according to this invention, utilizing genes from the characterised biosynthetic gene clusters. | 12-15-2011 |
| 20110294723 | Compounds - The present disclosure relates to compounds of formula (II): | 12-01-2011 |
| 20100179207 | COMPOUNDS - The present invention pertains generally to certain compounds of the deoxyactagardine A and B type. Such compounds are suitable for use in the treatment of microbial infections, for example | 07-15-2010 |
| 20100068770 | METHOD FOR THE CHEMO-SELECTIVE ENZYMATIC HYDROLYSIS IF A DIESTER COMPOUND FOR PREPARING A MONOESTER MONOACID COMPOUND - The invention relates to a synthesis process. | 03-18-2010 |
| 20090203583 | Use of Type-B Lantibiotic-Based Compounds having Antimicrobial Activity - The present invention provides methods for the treatment or prophylaxis of a microbial infection of the lower intestine or colon in a subject, the method comprising administering to the subject a type-B lantibiotic. In particular, the invention provides methods for the treatment or prophylaxis of a | 08-13-2009 |
